1. Antmann KH, Elias A, Ryan L (1990) Ifosfamide and mesna: response and toxicity at standard- and high-dose schedules. Semin Oncol 17 [Suppl 4]:68–73
2. Davies SM, Pearson ADJ, Craft AW (1989) Toxicity of high-dose ifosfamide in children. Cancer Chemother Pharmacol 24 [Suppl]:S8-S10
3. Elias A, Eder JP, Ayash L, Wheeler C, Deary J, Weissman L, Schryber S, Critchlow J, Hunt M, Schnipper L, Frei E III, Antman K (1990) A phase I study of ifosfamide (IFX) and carboplatin (Cb) with bone marrow transplantation. J Cancer Res Clin Oncol 116 [Suppl Part II]:822
4. Floersheim GL, Elson LA (1961) Wiederherstellung der Hämatopoese nach letaler Dosis von Dimethyl-Myleran durch isologe Knochenmarktransplantation bei Mäusen. Versuche zur Beeinflussung der Intoleranz gegenüber homologem Knochenmark durch 6-Mercaptopurin, Aminochlorambucil and Cortison. Acta Haematol 26:233–245
5. Gassmann W, Uharek L, Wottge H-U, Schmitz N, Loeffler H, Mueller-Ruchholtz W (1988) Comparison of cyclophosphamide, cytarabine, and etoposide as immuno-suppressive agents prior to allogeneic bone marrow transplantation. Blood 72:1574–1579